Gautam Patel - May 8, 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Director
Signature: /s/ Meredith Cook, Attorney-in-Fact
Stock symbol: AMRX
Transactions as of: May 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/10/2022, 07:04 PM
Previous filing: Dec 20, 2021
Next filing: Nov 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMRX	Class A Common Stock	Options Exercise		+35.4K	+13.68%		294K	May 8, 2022	Direct	F1
holding	AMRX	Class A Common Stock						12.9M	May 8, 2022	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMRX	Restricted Stock Units	Options Exercise	$0	-35.4K	-100%	$0.00^*	0	May 8, 2022	Class A Common Stock	35.4K		Direct	F1, F3
transaction	AMRX	Restricted Stock Units	Award	$0	+80.1K		$0.00	80.1K	May 9, 2022	Class A Common Stock	80.1K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2	By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3	On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022.
F4	Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.